Production (Stage)
Xenon Pharmaceuticals Inc.
XENE
$29.75
-$0.74-2.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.44% | -1.75% | 24.18% | 33.72% | 32.74% |
| Total Receivables | 938.30% | 68.08% | 16.52% | -59.82% | -62.51% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.24% | 14.72% | 32.79% | 97.06% | 65.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.03% | -1.50% | 24.22% | 33.69% | 32.60% |
|
|
|||||
| Total Current Assets | -20.03% | -1.50% | 24.22% | 33.69% | 32.60% |
| Net Property, Plant & Equipment | -5.27% | -3.34% | -6.65% | -3.36% | 1.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 145.68% | 109.34% | 7.30% | -2.16% | -5.79% |
| Total Assets | -19.12% | -17.27% | 24.56% | 29.07% | 27.67% |
|
|
|||||
| Total Accounts Payable | 7.03% | -41.03% | -11.02% | -21.02% | -43.66% |
| Total Accrued Expenses | 16.66% | 33.60% | 26.07% | 30.47% | 57.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.46% | 5.39% | 11.32% | 10.71% | 10.80% |
| Total Finance Division Other Current Liabilities | 6,512.26% | 1,744.38% | 909.35% | 1,106.59% | -86.13% |
| Total Other Current Liabilities | 6,512.26% | 1,744.38% | 909.35% | 1,106.59% | -86.13% |
| Total Current Liabilities | 44.13% | 30.50% | 20.01% | 11.10% | -1.19% |
|
|
|||||
| Total Current Liabilities | 44.13% | 30.50% | 20.01% | 11.10% | -1.19% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.87% | -20.39% | -13.92% | -15.60% | -12.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.53% | 17.24% | 10.41% | 3.96% | -4.86% |
|
|
|||||
| Common Stock & APIC | 4.17% | 3.94% | 29.39% | 32.38% | 32.09% |
| Retained Earnings | -35.26% | -35.23% | -34.40% | -34.80% | -35.96% |
| Treasury Stock & Other | 52.74% | -1,993.51% | 145.24% | 32.95% | 2.80% |
| Total Common Equity | -20.70% | -18.65% | 25.32% | 30.57% | 29.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.70% | -18.65% | 25.32% | 30.57% | 29.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.70% | -18.65% | 25.32% | 30.57% | 29.22% |
|
|
|||||